Part A: RNAi for Functional Genomics Screening Conference header


Cambridge Healthtech Institute’s 11th annual conference on RNAi for Functional Genomics Screening will cover the latest in the use of RNA interference (RNAi) screens for identifying and validating new drug targets and exploring unknown cellular pathways. It will cover everything from assay design to data analysis for the use of in vitro and in vivo siRNA (small interfering RNA) and shRNA (short hairpin RNA) screens, in a way that will evoke thought-provoking discussions and inspire collaborations. There is also a growing interest in combining RNAi screens with chemical genomics, phenotypic and next-generation sequencing (NGS) screens, which will all be discussed here. There will be talks on how to best utilize such combination screens, while bringing in other RNA based screens like, microRNA (miRNA) and long non-coding RNA (LncRNA) screens. Screening experts from pharma/biotech as well as from academic and government labs will share their experiences leveraging the utility of these diverse screening platforms for a wide range of applications. The conference will include oral presentations, posters, interactive panel discussions and technology workshops, where scientists can share best practices to figure out what works and what doesn’t and under what conditions.

Topics will include, but are not limited to: 

  • siRNA and shRNA screens
  • Pooled versus arrayed screening
  • Genome-wide versus targeted screening
  • Assay choices and design for RNAi screening
  • Emerging applications for in vivo RNAi screening
  • Utilizing combination screening (RNAi and small molecule screens)
  • Long non-coding RNA screens
  • Use of 3D cultures, co-cultures and organotypic cultures
  • Stem cell-based functional screening
  • Tackling off-target effects
  • Quality control, data analysis and standardization

Who should attend:Students, Post-docs, Lab Technicians, Managers, Scientists, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Drug Discovery, Functional Screening, Compound Screening, High-throughput screening, Target ID and validation, Hit-to-Lead Screening, Biomarker Discovery, Translational Research, Predictive Screening and Bioinformatics.

If you are interested in speaking, please click here to submit a proposal.

The deadline for submission is April 4, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.  Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For questions or suggestions about the meeting, please contact:
Tanuja Koppal, Ph.D.
Conference Director
Cambridge Healthtech Institute
T: (+1) 973-525-4667
E: tkoppal@healthtech.com 

For sponsorship and exhibit sales information including sponsored podium presentations, contact:
Jon Stroup
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

DOT CAG ICON 

green arrow CONFERENCE-AT-A-GLANCE 

PREMIER SPONSORS 

Cellecta 

green arrow VIEW ALL SPONSORS 

green arrow VIEW MEDIA PARTNERS 


SPONSORSHIPS & EXHIBITS 

The exhibit hall was sold out in 2013, so please contact us early to reserve your place. To customize your sponsorship or exhibit package for 2014, contact:

Jon Stroup
Business Development Manager
781-972-5483
jstroup@healthtech.com